欧洲发作性睡病市场至 2027 年 - 按类型划分的区域分析和预测（伴有猝倒的发作性睡病、不伴有猝倒的发作性睡病和继发性发作性睡病）；产品（中枢神经系统（CNS）兴奋剂、羟丁酸钠和抗抑郁药）；分销渠道（医院药房和零售药房）和国家
No. of Pages: 123 | Report Code: TIPRE00008098 | Category: Life Sciences
No. of Pages: 123 | Report Code: TIPRE00008098 | Category: Life Sciences
欧洲嗜睡症市场预计将从 2018 年的 6.711 亿美元增至 2027 年的 15.325 亿美元。预计 2019 年至 2027 年，嗜睡症市场将以 9.7% 的复合年增长率增长.
嗜睡症市场预计将增长，因为关键驱动因素包括不断增长的研究和开发以及整个地区意识的提高。然而，与发作性睡病相关的挑战等因素可能会成为市场增长的主要制约因素。
< p>发作性睡病是一种罕见的慢性睡眠障碍，是由于产生下丘脑分泌素的神经元丧失而引起的。已经取得了各种进展来制造可以减轻发作性睡病症状的药物。德国、英国和欧洲地区其他国家等国家正在进行多项研究和开发。例如，2019年4月，在德国，Inserm和德国大学开展了研发活动。德蒙彼利埃。该研究是与国际团队合作进行的，这些团队帮助在发作性睡病患者中开展 Solriamfetol 药物的流行病学和临床研究。
此外，该研究是与 Jazz Pharmaceuticals 合作进行的，该公司投资了该试验，并且还持有 Solriamfetol 的开发和商业化许可。该研究为III期临床试验，结果表明该药物对发作性睡病患者没有副作用。因此，由于嗜睡症的研发活动不断增加，可能会在预测期内促进市场的增长。
欧洲发作性睡病 –市场细分
欧洲发作性睡病市场 -按类型
欧洲市场 -副产品
欧洲市场 -按分销渠道
按地理位置
公司简介
Strategic insights for Europe Narcolepsy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 671.1 Million |
| Market Size by 2027 | US$ 1,532.5 Million |
| Global CAGR (2019 - 2027) | 9.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Narcolepsy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Europe Narcolepsy Market
The Europe Narcolepsy Market is valued at US$ 671.1 Million in 2018, it is projected to reach US$ 1,532.5 Million by 2027.
As per our report Europe Narcolepsy Market, the market size is valued at US$ 671.1 Million in 2018, projecting it to reach US$ 1,532.5 Million by 2027. This translates to a CAGR of approximately 9.7% during the forecast period.
The Europe Narcolepsy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Narcolepsy Market report:
The Europe Narcolepsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Narcolepsy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Narcolepsy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Narcolepsy Market
